CRE26-066: Clindamycin-Induced Immune-Mediated Thrombocytopenia: A Rare and Potentially Life-Threatening Adverse Reaction (First Reported U.S. Case to Our Knowledge)

Journal of the National Comprehensive Cancer Network 2026

View at publisher

Authors: Danyal Butt, Bibek Shrestha, Mamtha Balla, Asif Iqbal

DOI: 10.6004/jnccn.2025.7200

Cited by: 1

Fields of Study & Subjects

Platelet Disorders and Treatments Heparin-Induced Thrombocytopenia and Thrombosis Blood groups and transfusion